Global Corticosteroid API Market Growth 2023-2029

Global Corticosteroid API Market Growth 2023-2029

The global Corticosteroid API market size is projected to grow from US$ 5399.9 million in 2022 to US$ 7228 million in 2029; it is expected to grow at a CAGR of 4.3% from 2023 to 2029.

United States market for Corticosteroid API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Corticosteroid API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Corticosteroid API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Corticosteroid API players cover Pfizer, Novartis, Aspen, Euroapi, Sanofi, Avik Pharmaceutical Limited, Symbiotec, Cipla and Abbott Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Corticosteroids are synthetic analogs of the natural steroid hormones produced by the adrenal cortex and include glucocorticoids and mineralocorticoids. The synthetic hormones have varying degrees of glucocorticoid and mineralocorticoid properties. Glucocorticoids are predominantly involved in metabolism and have immunosuppressive, anti-inflammatory, and vasoconstrictive effects. Corticosteroid drugs (including cortisone, hydrocortisone and prednisone) are useful in treating many conditions, such as rashes, inflammatory bowel disease and asthma. Active Pharmaceutical Ingredient (API) is the biologically active component of a drug product (tablet, capsule, cream, injectable) that produces the intended effects.

LPI (LP Information)' newest research report, the “Corticosteroid API Industry Forecast” looks at past sales and reviews total world Corticosteroid API sales in 2022, providing a comprehensive analysis by region and market sector of projected Corticosteroid API sales for 2023 through 2029. With Corticosteroid API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Corticosteroid API industry.

This Insight Report provides a comprehensive analysis of the global Corticosteroid API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Corticosteroid API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Corticosteroid API market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Corticosteroid API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Corticosteroid API.

This report presents a comprehensive overview, market shares, and growth opportunities of Corticosteroid API market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Cortisone
Prednisone
Prednisolone
Methylprednisolone
Dexamethasone
Betamethasone
Hydrocortisone
Others

Segmentation by application
Anti-inflammatory
Immunosuppressive
Vasoconstrictive

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Novartis
Aspen
Euroapi
Sanofi
Avik Pharmaceutical Limited
Symbiotec
Cipla
Abbott Laboratories
Tianjin Tianyao Pharmaceuticals Co., Ltd.
Zhejiang Xianju Pharmaceutical Co.,Ltd
Shandong Xinhua Pharmaceutical Company Limited
Yangzi River Pharmaceutical Group

Key Questions Addressed in this Report

What is the 10-year outlook for the global Corticosteroid API market?

What factors are driving Corticosteroid API market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Corticosteroid API market opportunities vary by end market size?

How does Corticosteroid API break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.